Cost-Effectiveness of Fecal Immunochemical Testing Alone vs Co-Testing With Helicobacter pylori Stool Antigen - PubMed
3 hours ago
- #Cost-effectiveness analysis
- #Helicobacter pylori
- #Cancer screening
- Cost-effectiveness study comparing FIT alone versus co-testing with H pylori stool antigen.
- Co-testing was more effective and less expensive (dominant) in Taiwan.
- H pylori prevalence is the key driver; cost-effective when prevalence is above 21.9%.
- In the US, co-testing is cost-effective but not cost-saving at base-case prevalence.
- Study supports combined screening to reduce gastric and colorectal cancer mortality.